Improving PMTCT and Quality of HIV Treatment and STI Surveillance and Increasing Capacity to address needs for key populations in the Dominican Republic Ministry of Health under the President’s Emergency Plan for AIDS Relief (PEPFAR) | CDC RFA GH15 152002CONT16

Opportunity Information: Apply for CDC RFA GH15 152002CONT16

This funding opportunity is a continuation cooperative agreement from the Centers for Disease Control and Prevention (CDC) under the President's Emergency Plan for AIDS Relief (PEPFAR), focused on strengthening HIV and sexually transmitted infection (STI) programs within the Dominican Republic Ministry of Health. The stated programmatic priorities center on improving prevention of mother-to-child transmission (PMTCT) services, raising the quality of HIV treatment, strengthening STI surveillance systems, and expanding the country capacity to better address the needs of key populations that carry disproportionate HIV/STI risk and burden. In practical terms, the opportunity is designed to sustain and deepen work that helps the national health system prevent new pediatric HIV infections, ensure people living with HIV receive effective and consistent care, and improve the collection and use of surveillance data for STIs so that public health decisions are based on timely, accurate information.

The award is explicitly labeled as continuation funding, meaning it is not a standard open competition. The announcement states that funds are intended only for organizations that were previously awarded under the earlier related CDC notice, CDC-RFA-GH15-1520, which carried the same core program title and focus areas. Because of that restriction, the pool of eligible recipients is effectively limited to existing grantees already implementing this work, with the continuation mechanism used to maintain momentum, preserve staffing and partnerships, and avoid disrupting ongoing service delivery and technical support activities. The opportunity category is listed as "Continuation," and the funding instrument type is a cooperative agreement, which typically indicates CDC expects substantial involvement beyond simply providing funds, such as joint planning, technical guidance, monitoring, and collaboration on performance and reporting.

The activity category is health, and the CFDA number provided is 93.067, which is associated with global HIV/AIDS activities in the CDC portfolio. While the summary does not list a specific award ceiling (it is shown as 0), it does indicate this is part of an ongoing funding stream rather than a newly defined pot of money with a new maximum cap. Likewise, the "ExpectedAwards" field is not populated in the provided source data, which is consistent with continuation actions where the number of awards is tied to existing awards rather than a new cohort of grantees.

Operationally, the work implied by the title and description generally spans several interconnected domains. PMTCT improvement commonly includes strengthening antenatal HIV testing and counseling, ensuring rapid linkage of pregnant people living with HIV to antiretroviral therapy, supporting adherence and retention through pregnancy and breastfeeding, improving infant testing and follow-up, and tightening quality assurance so that PMTCT protocols are delivered consistently across facilities. Improving the quality of HIV treatment typically implies activities such as supporting national guidelines implementation, improving clinical mentoring and supervision, strengthening laboratory networks and viral load monitoring, upgrading patient tracking and appointment systems to reduce loss to follow-up, and advancing continuous quality improvement processes at clinics. Strengthening STI surveillance suggests investments in case reporting, sentinel surveillance where applicable, data quality checks, workforce training for surveillance staff, and better use of surveillance outputs to target prevention and treatment resources. Finally, increasing capacity to address key populations implies strengthening service delivery models that reach populations with elevated risk and barriers to care, improving referral pathways into HIV testing and treatment, integrating prevention and clinical services where possible, and supporting the Ministry of Health and partners to design services that are accessible, stigma-aware, and responsive to real-world needs.

From an administrative standpoint, the opportunity is identified by funding opportunity number CDC RFA GH15 152002CONT16, published by CDC, with an original closing date of 2015-12-06 and a creation date of 2015-10-06. Even though a closing date is listed, the continuation-only nature of the award makes the key takeaway that it is not meant for new applicants; it functions as an extension or continuation of an existing CDC/PEPFAR-supported project in the Dominican Republic. The eligible applicants field is summarized as "Others," but the description overrides this with the explicit limitation to prior awardees under the predecessor announcement.

• The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Improving PMTCT and Quality of HIV Treatment and STI Surveillance and Increasing Capacity to address needs for key populations in the Dominican Republic Ministry of Health under the President’s Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on 2015-10-06.
• Applicants must submit their applications by 2015-12-06. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: Others.

Apply for CDC RFA GH15 152002CONT16

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: